Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other financing activities (2018 - 2025)

CorMedix has reported Other financing activities over the past 7 years, most recently at -$94377.0 for Q4 2025.

  • Quarterly results put Other financing activities at -$94377.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $3.2 million (changed N/A YoY), and the annual figure for FY2025 was $188000.0, changed.
  • Other financing activities reached -$94377.0 in Q4 2025 per CRMD's latest filing, down from $49192.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $2.2 million in Q1 2023 and bottomed at -$94377.0 in Q4 2025.
  • Median Other financing activities over the past 3 years was $1.1 million (2022), compared with a mean of $906733.3.
  • Peak annual rise in Other financing activities hit 94.71% in 2023, while the deepest fall reached 1.52% in 2023.
  • Over 3 years, Other financing activities stood at $1.1 million in 2022, then dropped by 1.52% to $1.1 million in 2023, then plummeted by 108.93% to -$94377.0 in 2025.
  • Business Quant data shows Other financing activities for CRMD at -$94377.0 in Q4 2025, $49192.0 in Q3 2025, and $1.1 million in Q2 2023.